Dkk-1

Dkk-1 Overview

English NameDickkopf-related protein 1Approved Drugs0
Drugs in Clinical Trials4Target SynonymDickkopf-Like Protein 1,Dickkopf 1 Homolog,Dickkopf-1 Like,Dickkopf-1,Dkk-1,UNQ492/PRO1008,Dickkopf-related protein 1,hDkk-1,SK,DKK1,Dickkopf WNT Signaling Pathway Inhibitor 1,Dickkopf 1 Homolog (Xenopus Laevis),Dickkopf (Xenopus Laevis) Homolog 1
Highest Development StagePhase 2 Clinical
English NameDickkopf-related protein 1
Target SynonymDickkopf-Like Protein 1,Dickkopf 1 Homolog,Dickkopf-1 Like,Dickkopf-1,Dkk-1,UNQ492/PRO1008,Dickkopf-related protein 1,hDkk-1,SK,DKK1,Dickkopf WNT Signaling Pathway Inhibitor 1,Dickkopf 1 Homolog (Xenopus Laevis),Dickkopf (Xenopus Laevis) Homolog 1
Approved Drugs0
Drugs in Clinical Trials4
Highest Development StagePhase 2 Clinical

Dkk-1 Product List

  • Product Category

    Protein (4)

  • Product Status

    Launched (4)

  • Species

    Human (3)Mouse (1)

  • Tag

    His Tag (2)Fc Tag (1)Fc Tag & Avi Tag (1)

  • Conjugate

    Unconjugated (3)Biotin-labeled (1)

Dkk-1 Background

Members of the dickkopf-related protein family (DKK-1, -2, -3, and -4) are secreted proteins with two cysteine-rich domains separated by a linker region. And DKK1 takes part in embryonic development through its inhibition of the WNT signaling pathway, binds to LRP6 with high affinity and prevents the Frizzled-Wnt-LRP6 complex formation in response to Wnts. DKK1 promotes LRP6 internalization and degradation when it forms a ternary complex with the cell surface receptor Kremen.DKK1 not olny functions as a head inducer during development, but also regulates joint remodeling and bone formation, which suggests roles for DKK1 in the pathogenesis of rheumatoid arthritis and multiple myeloma. More recently research reported, DKK1 impacts eye development from a defined developmental time point on, and is critical for lens separation from the surface ectoderm via β-catenin mediated Pdgfrα and E-cadherin expression.

Dkk-1 Synonyms

DKK1,SK

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
JS-015JS-015Phase 2 ClinicalShanghai Junshi Biological Engineering Co LtdColorectal Neoplasms; Neoplasms; Solid tumours
Details
AGA-2115AGA2115; AGA-2115Phase 2 ClinicalAngitia Biopharmaceuticals (Guangzhou) LtdOsteogenesis Imperfecta
Details
AGA-2118AGA-2118Phase 2 ClinicalAngitia Biomedicines LtdOsteoporosis; Osteoporosis, Postmenopausal
Details
SirexatamabDKN-01; LY-2812176Phase 2 ClinicalEli Lilly And CompanyBile Duct Neoplasms; Biliary Tract Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Carcinosarcoma; Cholangiocarcinoma; Colorectal Neoplasms; Endometrial Neoplasms; Esophageal Neoplasms; Gallbladder Neoplasms; Liver Neoplasms; Multiple Myeloma; Ovarian Neoplasms; Prostatic Neoplasms; Solid tumours; Stomach Neoplasms; Uterine Neoplasms
Details
  • Overview
  • Product List
  • Clinical Drug Information
Contact Us

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521

[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland